A road map for the treatment of pediatric diffuse midline glioma

- Koschmann, Carl, Al-Holou, Wajd N., Clausen, Madison, Dang, Derek, Doherty, Robert, Duchatel, Ryan, Dun, Matthew, Filbin, Mariella, Franson, Andrea, Galban, Stefanie, Garcia Moure, Marc, Garton, Hugh, Alonso, Marta M., Gowda, Pruthvi, Marques, JG, Hawkins, C, Heath, A, Hulleman, E, Ji, S, Jones, C, Kilburn, L, Kline, C, Koldobskiy, MA, Anastas, Jamie, Lim, D, Lowenstein, PR, Lu, QR, Lum, J, Mack, S, Magge, S, Marini, B, Martin, D, Marupudi, N, Messinger, D, Bandopadhayay, Pratiti, Mody, R, Morgan, M, Mota, M, Muraszko, K, Mueller, S, Natarajan, SK, Nazarian, J, Niculcea, M, Nuechterlein, N, Okada, H, Barron, Tara, Opipari, V, Pai, MP, Pal, S, Peterson, E, Phoenix, T, Prensner, JR, Pun, M, Raju, GP, Reitman, ZJ, Resnick, A, Becher, Oren, Rogawski, D, Saratsis, A, Sbergio, SG, Souweidane, M, Stafford, JM, Tzaridis, T, Venkataraman, S, Vittorio, O, Wadden, J, Wahl, D, Cartaxo, Rodrigo, Wechsler-Reya, RJ, Yadav, VN, Zhang, X, Zhang, Q, Venneti, S, Castro, Maria G., Chung, Chan

Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

- Venneti, Sriram, Kawakibi, Abed Rahman, Ramage, Samuel, Chi, Andrew, Wen, Patrick Y., Arrillaga-Romany, Isabel, Batchelor, Tracy T., Butowski, Nicholas A., Sumrall, Ashley, Shonka, Nicole, Harrison, Rebecca A., de Groot, John, Ji, Sunjong, Mehta, M, Hall, MD, Daghistani, D, Cloughesy, TF, Ellingson, BM, Beccaria, K, Varlet, P, Kim, MM, Umemura, Y, Garton, H, Waszak, Sebastian M., Franson, A, Schwartz, J, Jain, R, Kachman, M, Baum, H, Burant, CF, Mottl, SL, Cartaxo, RT, John, V, Messinger, D, Sweha, StefanR, Qin, T, Peterson, E, Sajjakulnukit, P, Ravi, K, Waugh, A, Walling, D, Ding, Y, Xia, Z, Schwendeman, A, Hawes, D, Mota, Mateus, Yang, F, Judkins, AR, Wahl, D, Lyssiotis, CA, de la Nava, D, Alonso, MM, Eze, A, Spitzer, J, Schmidt, SV, Duchatel, Ryan J., Pun, Matthew, Dun, Matthew D., Cain, JE, Jiang, L, Stopka, SA, Baquer, G, Regan, MS, Filbin, MG, Agar, NYR, Zhao, L, Kumar-Sinha, C, Deogharkar, Akash, Mody, R, Chinnaiyan, A, Kurokawa, R, Pratt, D, Yadav, VN, Grill, J, Kline, C, Mueller, S, Resnick, A, Nazarian, J, Chung, Chan, Allen, JE, Odia, Y, Gardner, SL, Koschmann, C, Tarapore, Rohinton S.

Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities

- Sun, Claire Xin, Daniel, Paul, Adjumain, Shazia, Sun, Christie, Chong, Wai Chin, Fernando, Dasun, Drinkwater, Caroline, Tourchi, Motahhareh, Habarakada, Dilru, Sooraj, Dhanya, Carvalho, Diana, Storm, Phillip B., Bradshaw, Gabrielle, Baubet, Valerie, Sayles, LC, Fernandez, E, Nguyen, T, Pörksen, M, Doan, A, Crombie, DE, Panday, M, Zhukova, N, Dun, Matthew D., Shi, Hui, Ludlow, LE, Day, B, Stringer, BW, Neeman, N, Rubens, JA, Raabe, EH, Vinci, M, Tyrrell, V, Fletcher, JI, Ekert, PG, Loi, Melissa, Dumevska, B, Ziegler, DS, Tsoli, M, Syed Sulaiman, NF, Loh, AHP, Low, SYY, Sweet-Cordero, EA, Monje, M, Resnick, A, Jones, C, Chew, Nicole, Downie, P, Williams, B, Rosenbluh, J, Gough, D, Cain, JE, Firestein, R, Parackal, Sarah, Tsui, Vanessa, Liang, Yuqing, Koptyra, Mateusz

The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location

- Liu, Ilon, Jiang, Li, Mire, Hafsa M., Madlener, Sibylle, Mayr, Lisa, Quezada, Michael A., Trissal, Maria, Panditharatna, Eshini, Ernst, Kati J., Vogelzang, Jayne, Gatesman, Taylor A., Halbert, Matthew E., Samuelsson, Erik R., Palova, Hana, Pokorna, P, Sterba, J, Slaby, O, Geyeregger, R, Diaz, A, Findlay, Izac J., Dun, Matthew D., Resnick, A, Suvà, ML, Marco Salas, Sergio, Jones, DTW, Agnihotri, S, Svedlund, J, Koschmann, C, Haberler, C, Czech, T, Slavc, I, Cotter, JA, Ligon, KL, Alexandrescu, S, Beck, Alexander, Yung, WKA, Arrillaga-Romany, I, Gojo, J, Monje, M, Nilsson, M, Filbin, MG, Hack, Olivia A., Jeong, Daeun, Shaw, McKenzie L., Englinger, Bernhard, LaBelle, Jenna